New ANDA Cases

Winter 2017

GENERICally Speaking
Case Name Date Filed Judge Drug Patent No(s).
Purdue Pharma L.P. v. Alvogen Pine Brook, LLC, 17-1369 (D. Del.) Oct. 2, 2017 Hon. Gregory M. Sleet Hysingla® ER (hydrocodone bitartrate extended-release tablets)
9,750,703
9,763,933
9,770,416
9,775,809
Boehringer Ingelheim Pharms., Inc. v. Aurobindo Pharma USA Inc., 17-7887 (D.N.J.) Oct. 4, 2017 Hon. Michael A. Shipp Gilotrif® (afatinib dimaleate tablets) 8,426,586
Forest Labs. Holdings, Ltd. v. Strides Pharma Global PTE Ltd., 17-1394 (D. Del.) Oct. 5, 2017 Hon. Gregory M. Sleet Savella® (milnacipran HCl tablets)
6,602,911
7,888,342
7,994,220
Boehringer Ingelheim Pharms., Inc. v. Hetero USA Inc., 17-7923 (D.N.J.) Oct. 5, 2017 Hon. Michael A. Shipp Gilotrif® (afatinib dimaleate tablets) 8,426,586
Purdue Pharma L.P. v. Collegium Pharm., Inc., 17-cv-11923 (D. Mass.) Oct. 6, 2017 Hon. F. Dennis Saylor, IV Xtampza® ER (oxycodone extended-release capsules)XXOxyContin® (oxycodone HCl extended-release tablets)
9,522,919
9,073,933
Forest Labs. Holdings, Ltd. v. Strides Pharma Global PTE Ltd., 17-7996 (D.N.J.) Oct. 6, 2017 Hon. Brian R. Martinotti Savella® (milnacipran HCl tablets)
6,602,911
7,888,342
7,994,220
Indivior Inc. v. Par Pharm., Inc., 17-7997 (D.N.J.) Oct. 6, 2017 Hon. Kevin McNulty Suboxone® (buprenorphine HCl / naloxone HCl sublingual film) 9,687,454
Insys Therapeutics, Inc. v. Alkem Labs. Ltd., 17-1419 (D. Del.) Oct. 10, 2017 Hon. Leonard P. Stark Syndros® (dronabinol oral solution)
8,222,292
9,345,771
Purdue Pharma L.P. v. Amneal Pharms., LLC, LLC 17-1421 (D. Del.) Oct. 10, 2017 Hon. Richard G. Andrews OxyContin® (oxycodone HCl extended-release tablets)
9,763,886
9,763,933
9,675,610
Noven Pharms., Inc. v. Alvogen Pine Brook LLC, 17-1429 (D. Del.) Oct. 11, 2017 Hon. Leonard P. Stark Minivelle® (estradiol transdermal system)
9,730,900
9,724,310
Amarin Pharma, Inc. v. Teva Pharms. USA, Inc., 17-2641 (D. Nev.) Oct. 11, 2017 Hon. Miranda M. Du Vascepa® (icosapent ethyl capsules)
8,293,728
8,318,715
8,357,677
8,367,652
8,377,920
8,415,335
8,426,399
8,440,650
8,518,929
8,524,698
8,546,372
8,617,594
Hoffmann-La Roche Inc. v. Airis Pharma Private Ltd., 17-7912 (S.D.N.Y.) Oct. 13, 2017 Hon. Katherine B. Forrest Valcyte® (valganciclovir HCl oral solution)
9,642,911
8,889,109
Boehringer Ingelheim Pharms., Inc. v. MSN Labs. Private Ltd., 17-8399 (D.N.J.) Oct. 16, 2017 Hon. Michael A. Shipp Gilotrif® (afatinib dimaleate tablets) 8,426,586
Sawai USA, Inc. v. Astellas Pharma Inc., IPR2018-00079 (PTAB) Oct. 16, 2017 N/A Myrbetriq® (mirabegron extended-release tablets) 6,346,532
Takeda Pharms. U.S.A., Inc. v. Macleods Pharms. Ltd., 17-1469 (D. Del.) Oct. 17, 2017 Hon. Richard G. Andrews Colcrys® (colchicine tablets)
7,906,519
7,935,731
8,093,298
7,964,648
8,093,297
7,619,004
7,601,758
7,820,681
7,915,269
7,964,647
7,981,938
8,093,296
8,097,655
8,415,395
8,415,396
8,440,721
8,440,722
Acrux DDS Pty Ltd. v. Sandoz, Inc., 17-3824 (S.D. Ind.) Oct. 23, 2017 Hon. Sarah Evans Barker Axiron® (testosterone topical solution)
8,435,944
8,993,520
9,180,194
Bristol-Myers Squibb Co. v. Apotex Inc., 17-1493 (D. Del.) Oct. 24, 2017 Hon. Leonard P. Stark Reyataz® (atazanavir sulfate capsules) 6,087,383
Sanofi-Aventis U.S. LLC v. Mylan N.V., 17-9105 (D.N.J.) Oct. 24, 2017 Hon. Stanley R. Chesler Lantus® (insulin glargine injection)XXLantus® SoloSTAR® (insulin glargine injection)
7,476,652
7,713,930
7,918,833
8,512,297
8,556,864
8,603,044
8,679,069
8,992,486
9,011,391
9,233,211
9,408,979
9,526,844
9,533,105
9,561,331
9,604,008
9,604,009
9,610,409
9,623,189
Acrux DDS Pty Ltd. v. Sandoz, Inc., 17-2558 (D. Col.) Oct. 25, 2017 Hon. Nina Y. Wang Axiron® (testosterone topical solution)
8,435,944
8,993,520
9,180,194
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. v. Gilead Pharmasset LLC, IPR2018-00119 (PTAB) Oct. 25, 2017 N/A Sovaldi® (sofosbuvir tablets)XXHarvoni® (ledipasvir / sofosbuvir tablets)XXEpclusa® (sofosbuvir / velpatasvir tablets)XXVosevi® (sofosbuvir / velpatasvir / voxilaprevir tablets) 7,964,580
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. v. Gilead Pharmasset LLC, IPR2018-00120 (PTAB) Oct. 25, 2017 N/A Sovaldi® (sofosbuvir tablets)XXHarvoni® (ledipasvir / sofosbuvir tablets)XXEpclusa® (sofosbuvir / velpatasvir tablets)XXVosevi® (sofosbuvir / velpatasvir / voxilaprevir tablets) 7,964,580
Sanofi-Aventis U.S. LLC v. Mylan N.V., 17-0181 (N.D.W.V.) Oct. 26, 2017 Hon. Irene M. Keeley Lantus® (insulin glargine injection)XXLantus® SoloSTAR® (insulin glargine injection)
7,476,652
7,713,930
7,918,833
8,512,297
8,556,864
8,603,044
8,679,069
8,992,486
9,011,391
9,233,211
9,408,979
9,526,844
9,533,105
9,561,331
9,604,008
9,604,009
9,610,409
9,623,189
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. v. Gilead Pharmasset LLC, IPR2018-00121 (PTAB) Oct. 26, 2017 N/A Sovaldi® (sofosbuvir tablets)XXHarvoni® (ledipasvir / sofosbuvir tablets)XXEpclusa® (sofosbuvir / velpatasvir tablets)XXVosevi® (sofosbuvir / velpatasvir / voxilaprevir tablets) 8,334,270
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. v. Gilead Pharmasset LLC, IPR2018-00122 (PTAB) Oct. 26, 2017 N/A Sovaldi® (sofosbuvir tablets)XXHarvoni® (ledipasvir / sofosbuvir tablets)XXEpclusa® (sofosbuvir / velpatasvir tablets)XXVosevi® (sofosbuvir / velpatasvir / voxilaprevir tablets) 8,334,270
Pfizer Inc. v. Breckenridge Pharm., Inc., 17-1532 (D. Del.) Oct. 30, 2017 Hon. Leonard P. Stark Xeljanz® (tofacitinib tablets)
6,956,041
7,091,208
7,265,221
RE41,783
Recro Gainesville LLC v. Actavis Labs. FL, Inc., 17-1535 (D. Del.) Oct. 30, 2017 Hon. Gregory M. Sleet Zohydro® (hydrocodone bitartrate extended-release capsules) 9,713,611
Allergan Sales, LLC v. Sandoz, Inc., 17-10129 (D.N.J.) Oct. 30, 2017 Hon. William H. Walls Combigan® (brimonidine tartrate / timolol maleate ophthalmic solution) 9,770,453
Forest Labs., LLC v. MSN Labs. Private Ltd., 17-10140 (D.N.J.) Oct. 30, 2017 Hon. Esther Salas Fetzima® (levomilnacipran HCl extended-release capsules)
8,481,598
8,865,937
RE43,879
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. v. Gilead Pharmasset LLC, IPR2018-00125 (PTAB) Oct. 30, 2017 N/A Sovaldi® (sofosbuvir tablets)XXHarvoni® (ledipasvir / sofosbuvir tablets)XXEpclusa® (sofosbuvir / velpatasvir tablets)XXVosevi® (sofosbuvir / velpatasvir / voxilaprevir tablets) 8,633,309
Pfizer Inc. v. Umedica Labs. Pvt., Ltd., 17-1551 (D. Del.) Oct. 31, 2017 Hon. Richard G. Andrews Viagra® (sildenafil citrate tablets) 6,469,012
iCeutica Pty Ltd v. Apotex, Inc., 17-1553 (D. Del.) Oct. 31, 2017 Vacant Judgeship (2017) Zorvolex® (diclofenac capsules)
8,679,544
8,999,387
9,017,721
9,173,854
9,180,095
9,180,096
9,186,328
iCeutica Pty Ltd v. Apotex Inc., 17-1554 (D. Del.) Oct. 31, 2017 Vacant Judgeship (2017) Vivlodex® (meloxicam capsules)
9,526,734
9,649,318
Forest Labs., LLC v. Prinston Pharm Inc., 17-10230 (D.N.J.) Oct. 31, 2017 Hon. Esther Salas Fetzima® (levomilnacipran HCl extended-release capsules)
8,481,598
8,865,937
RE43,879
Forest Labs., LLC v. Torrent Pharms. Ltd., 17-10273 (D.N.J.) Oct. 31, 2017 Hon. Esther Salas Fetzima® (levomilnacipran HCl extended-release capsules)
8,481,598
8,865,937
RE43,879
Forest Labs., LLC v. Westward Pharms. Int'l Ltd., 17-10321 (D.N.J.) Oct. 31, 2017 Hon. Esther Salas Fetzima® (levomilnacipran HCl extended-release capsules)
8,481,598
8,865,937
RE43,879
Forest Labs., LLC v. Zydus Pharms. (USA) Inc., 17-10330 (D.N.J.) Oct. 31, 2017 Hon. Esther Salas Fetzima® (levomilnacipran HCl extended-release capsules)
8,481,598
8,865,937
RE43,879
Hospira, Inc. v. Presenius Kabi USA, LLC, 17-7903 (N.D. Ill.) Nov. 1, 2017 Hon. Rebecca R. Pallmeyer Precedex® (dexmedetomidine HCl injection) 9,616,049
ViiV Healthcare Co. v. Lupin Ltd., 17-1576 (D. Del.) Nov. 2, 2017 Vacant Judgeship (2017) Triumeq® (abacavir / dolutegravir / lamivudine tablets) 9,242,986
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. v. Gilead Pharmasset LLC, IPR2018-00126 (PTAB) Nov. 2, 2017 N/A Sovaldi® (sofosbuvir tablets)XXHarvoni® (ledipasvir / sofosbuvir tablets)XXEpclusa® (sofosbuvir / velpatasvir tablets)XXVosevi® (sofosbuvir / velpatasvir / voxilaprevir tablets) 9,284,342
Pfizer Inc. v. Sun Pharm. Indus. Ltd., 17-1597 (D. Del.) Nov. 7, 2017 Hon. Leonard P. Stark Xeljanz XR® (tofacitinib extended-release tablets) RE41,783
Mayne Pharma Int'l Pty Ltd. v. Actavis Elizabeth LLC, 17-1614 (D. Del.) Nov. 9, 2017 Vacant Judgeship (2017) Doryx® MPC (doxycycline hyclate delayed-release tablets)
6,958,161
9,295,652
9,446,057
9,511,031
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. v. Gilead Pharmasset LLC, IPR2018-00123 (PTAB) Nov. 9, 2017 N/A Harvoni® (ledipasvir / sofosbuvir tablets)XXEpclusa® (sofosbuvir / velpatasvir tablets)XXVosevi® (sofosbuvir / velpatasvir / voxilaprevir tablets) 8,735,372
Apotex Inc. v. Abraxis Bioscience, LLC, IPR2018-00151 (PTAB) Nov. 9, 2017 N/A Abraxane® (paclitaxel for injection) 8,138,229
Apotex Inc. v. Abraxis Bioscience, LLC, IPR2018-00152 (PTAB) Nov. 9, 2017 N/A Abraxane® (paclitaxel for injection) 7,820,788
Apotex Inc. v. Abraxis Bioscience, LLC, IPR2018-00153 (PTAB) Nov. 9, 2017 N/A Abraxane® (paclitaxel for injection) 7,923,536
Cipla Ltd. v. Abraxis Bioscience, LLC, IPR2018-00162 (PTAB) Nov. 9, 2017 N/A Abraxane® (paclitaxel for injection) 7,820,788
Cipla Ltd. v. Abraxis Bioscience, LLC, IPR2018-00163 (PTAB) Nov. 9, 2017 N/A Abraxane® (paclitaxel for injection) 7,923,536
Cipla Ltd. v. Abraxis Bioscience, LLC, IPR2018-00164 (PTAB) Nov. 9, 2017 N/A Abraxane® (paclitaxel for injection) 8,138,229
AbbVie Inc. v. Cipla Ltd., 17-1631 (D. Del.) Nov. 10, 2017 Hon. Richard G. Andrews Kaletra® (lopinavir / ritonavir tablets)
7,148,359
7,364,752
8,025,899
8,268,349
8,309,613
8,377,952
8,399,015
8,470,347
8,691,878
ViiV Healthcare Co. v. Apotex Inc., 17-1634 (D. Del.) Nov. 10, 2017 Vacant Judgeship (2017) Triumeq® (abacavir / dolutegravir / lamivudine tablets)XXTivicay® (dolutegravir tablets) 9,242,986
Boehringer Ingelheim Pharms., Inc. v. Teva Pharms. USA, Inc., 17-11510 (D.N.J.) Nov. 10, 2017 Hon. Michael A. Shipp Gilotrif® (afatinib tablets)
RE43,431
8,426,586
Mayne Pharma Int'l Pty Ltd. v. Lupin Ltd., 17-1637 (D. Del.) Nov. 13, 2017 Vacant Judgeship (2017) Doryx® MPC (doxycycline hyclate delayed-release tablets)
9,295,652
9,446,057
9,511,031
AstraZeneca LP v. Prinston Pharm. Inc., 17-1639 (D. Del.) Nov. 13, 2017 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
6,251,910
RE 46,276
7,250,419
7,265,124
Par Pharm., Inc. v. Indivior Inc., 17-1280 (E.D. Va.) Nov. 13, 2017 Hon. Claude M. Hilton Suboxone® (buprenorphine HCl / naloxone HCl sublingual film) 9,687,454
Delcor Asset Corp. v. Glenmark Pharms. Ltd., 17-1653 (D. Del.) Nov. 15, 2017 Hon. Richard G. Andrews Evoclin® (clindamycin phosphate aerosol, foam)
7,141,237
7,374,747
Forest Labs., LLC v. Aurobindo Pharma USA, Inc., 17-11679 (D.N.J.) Nov. 15, 2017 Hon. Esther Salas Fetzima® (levomilnacipran HCl extended-release capsules)
8,481,598
8,865,937
RE43,879
Forest Labs., LLC v. Amneal Pharms. LLC, 17-11680 (D.N.J.) Nov. 15, 2017 Hon. Esther Salas Fetzima® (levomilnacipran HCl extended-release capsules)
8,481,598
8,865,937
RE43,879
Eli Lilly and Co. v. Actavis LLC, 17-4299 (S.D. Ind.) Nov. 16, 2017 Hon. Tanya Walton Pratt Alimta® (pemetrexed for injection) 7,772,209
ViiV Healthcare Co. v. Cipla Ltd., 17-1670 (D. Del.) Nov. 17, 2017 Vacant Judgeship (2017) Triumeq® (abacavir / dolutegravir / lamivudine tablets) 9,242,986
ViiV Healthcare Co. v. Mylan Pharms. Inc., 17-1671 (D. Del.) Nov. 17, 2017 Vacant Judgeship (2017) Triumeq® (abacavir / dolutegravir / lamivudine tablets) 9,242,986
ViiV Healthcare Co. v. Mylan Pharms. Inc., 17-0197 (N.D.W.V.) Nov. 17, 2017 Hon. Irene M. Keeley Triumeq® (abacavir / dolutegravir / lamivudine tablets) 9,242,986
ViiV Healthcare Co. v. Dr. Reddy's Labs., Inc., 17-1678 (D. Del.) Nov. 20, 2017 Vacant Judgeship (2017) Triumeq® (abacavir / dolutegravir / lamivudine tablets) 9,242,986
ViiV Healthcare Co. v. Dr. Reddy's Labs., Inc., 17-11873 (D.N.J.) Nov. 20, 2017 Hon. Brian R. Martinotti Triumeq® (abacavir / dolutegravir / lamivudine tablets) 9,242,986
Takeda Pharms. U.S.A., Inc. v. Strides Pharma Global PTE Ltd., 17-1690 (D. Del.) Nov. 21, 2017 Hon. Richard G. Andrews Colcrys® (colchicine tablets)
7,906,519
7,935,731
8,093,298
7,964,648
8,093,297
7,619,004
7,601,758
7,820,681
7,915,269
7,964,647
7,981,938
8,093,296
8,097,655
8,415,395
8,415,396
8,440,721
8,440,722
Flatwing Pharms., LLC v. Anacor Pharms., Inc., IPR2018-00168 (PTAB) Nov. 21, 2017 N/A Kerydin® (tavaborole topical solution) 9,549,938
Flatwing Pharms., LLC v. Anacor Pharms., Inc., IPR2018-00169 (PTAB) Nov. 21, 2017 N/A Kerydin® (tavaborole topical solution) 9,566,289
Flatwing Pharms., LLC v. Anacor Pharms., Inc., IPR2018-00170 (PTAB) Nov. 21, 2017 N/A Kerydin® (tavaborole topical solution) 9,566,290
Flatwing Pharms., LLC v. Anacor Pharms., Inc., IPR2018-00171 (PTAB) Nov. 21, 2017 N/A Kerydin® (tavaborole topical solution) 9,572,823
Shire Development LLC v. Teva Pharms. USA, Inc., 17-1696 (D. Del.) Nov. 22, 2017 Hon. Richard G. Andrews Mydayis® (amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate extended-release capsules)
6,913,768
8,846,100
9,173,857
Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc., 17-1699 (D. Del.) Nov. 22, 2017 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection)
7,417,042
7,232,818
7,491,704
7,737,112
8,129,346
8,207,125
8,207,126
8,207,127
8,207,297
Mitsubishi Tanabe Pharma Corp. v. Aurobindo Pharma USA Inc., 17-12082 (D.N.J.) Nov. 27, 2017 Hon. Freda L. Wolfson Invokana® (canagliflozin tablets)
7,943,788
8,222,219
Forest Labs., LLC v. Mylan Pharms. Inc., 17-1728 (D. Del.) Nov. 30, 2017 Hon. Richard G. Andrews Linzess® (linaclotide capsules) 9,708,371
ViiV Healthcare Co. v. Dr. Reddy's Labs., Inc., 17-1737 (D. Del.) Dec. 1, 2017 Vacant Judgeship (2017) Tivicay® (dolutegravir tablets) 9,242,986
ViiV Healthcare Co. v. Dr. Reddy's Labs., Inc., 17-12374 (D.N.J.) Dec. 1, 2017 Hon. Brian R. Martinotti Tivicay® (dolutegravir tablets) 9,242,986
ViiV Healthcare Co. v. Cipla Ltd., 17-1741 (D. Del.) Dec. 4, 2017 Vacant Judgeship (2017) Tivicay® (dolutegravir tablets) 9,242,986
Mylan Technologies, Inc. v. Noven Pharms., Inc., IPR2018-00173 (PTAB) Dec. 4, 2017 N/A Minivelle® (estradiol extended-release film) 9,724,310
Mylan Technologies, Inc. v. Noven Pharms., Inc., IPR2018-00174 (PTAB) Dec. 4, 2017 N/A Minivelle® (estradiol extended-release film) 9,730,900
Mylan Pharms. Inc. v. Pozen Inc., IPR2018-00272 (PTAB) Dec. 4, 2017 N/A Vimovo® (esomeprazole magnesium / naproxen delayed-release tablets) 9,393,208
Leo Pharma A/S v. Actavis Labs. UT, Inc., 17-1752 (D. Del.) Dec. 6, 2017 Hon. Joseph F. Bataillon Picato® (ingenol mebutate gel)
9,820,959
9,833,428
9,833,429
Leo Pharma A/S v. Perrigo UK Finco Ltd., 17-1753 (D. Del.) Dec. 6, 2017 Hon. Joseph F. Bataillon Picato® (ingenol mebutate gel)
9,820,959
9,833,428
9,833,429
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. v. Gilead Pharmasset LLC, IPR2018-00211 (PTAB) Dec. 6, 2017 N/A Harvoni® (ledipasvir / sofosbuvir tablets) 9,393,256
Chiesi U.S.A., Inc. v. Teva Pharms. USA, Inc., 17-1772 (D. Del.) Dec. 7, 2017 Vacant Judgeship (2017) Bethkis® (tobramycin injection solution)
6,987,094
7,696,178
7,939,502
Pfizer Inc. v. Aurobindo Pharma USA Inc., 17-1775 (D. Del.) Dec. 8, 2017 Hon. Leonard P. Stark Tikosyn® (dofetilide capsules) 6,124,363
Noven Pharms., Inc. v. Mylan Technologies Inc., 17-1777 (D. Del.) Dec. 8, 2017 Hon. Leonard P. Stark Minivelle® (estradiol extended-release film)
9,730,900
9,724,310
Valeant Pharms. Int'l, Inc. v. Actavis Labs. FL, Inc., 17-12857 (D.N.J.) Dec. 8, 2017 Hon. Stanley R. Chesler Relistor® (methylnaltrexone bromide tablets)
9,724,343
9,492,445
Merck Sharp & Dohme Corp. v. Teva Pharms. USA, Inc., 17-6921 (D.N.J.) Sept. 8, 2017 Hon. Michael A. Shipp Entereg® (alvimopan capsules)
6,469,030
8,946,262
ViiV Healthcare Co. v. Sandoz Inc., 17-1784 (D. Del.) Dec. 11, 2017 Vacant Judgeship (2017) Tivicay® (dolutegravir tablets) 9,242,986
ViiV Healthcare Co. v. Sandoz Inc., 17-12912 (D. Del.) Dec. 11, 2017 Hon. Brian R. Martinotti Tivicay® (dolutegravir tablets) 9,242,986
KVK-Tech, Inc. v. Shire PLC, IPR2018-00290 (PTAB) Dec. 11, 2017 N/A Mydayis® (amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate extended-release capsules) 8,846,100
KVK-Tech, Inc. v. Shire PLC, IPR2018-00293 (PTAB) Dec. 11, 2017 N/A Mydayis® (amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate extended-release capsules) 9,173,857
Teva Pharms. Int'l GMBH v. Mylan Labs. Ltd., 17-1790 (D. Del.) Dec. 12, 2017 Hon. Gregory M. Sleet Bendeka® (bendamustine HCl for injection)
8,791,270
8,609,707
9,265,831
9,572,796
9,572,797
9,034,908
9,144,568
9,572,887
9,597,397
9,597,398
9,597,399
9,000,021
9,579,384
Neos Therapeutics, Inc. v. Teva Pharms. USA, Inc., 17-1793 (D. Del.) Dec. 13, 2017 Hon. Gregory M. Sleet Cotempla XR-ODT® (methylphenidate extended-release orally disintegrating tablets)
8,840,924
9,072,680
9,089,496
AstraZeneca Pharms. LP v. Fresenius Kabi USA, LLC, 17-1795 (D. Del.) Dec. 14, 2017 Vacant Judgeship (2017) Faslodex® (fulvestrant for injection)
6,774,122
7,456,160
8,329,680
8,466,139
AstraZeneca Pharms. LP v. Fresenius Kabi USA, LLC, 17-13075 (D.N.J.) Dec. 14, 2017 Hon. Renee Marie Bumb Faslodex® (fulvestrant for injection)
6,774,122
7,456,160
8,329,680
8,466,139
Amgen Inc. v. Watson Labs., Inc., 17-1807 (D. Del.) Dec. 15, 2017 Hon. Gregory M. Sleet Sensipar® (cinacalcet HCl tablets) 9,375,405
Amgen Inc. v. Barr Labs., Inc., 17-1808 (D. Del.) Dec. 15, 2017 Hon. Gregory M. Sleet Sensipar® (cinacalcet HCl tablets) 9,375,405
Amgen Inc. v. Teva Pharms. USA, Inc., 17-1809 (D. Del.) Dec. 15, 2017 Hon. Gregory M. Sleet Sensipar® (cinacalcet HCl tablets) 9,375,405
Mitsubishi Tanabe Pharma Corp. v. Macleods Pharms., Ltd., 17-13130 (D.N.J.) Dec. 15, 2017 Hon. Peter G. Sheridan Invokana® (canagliflozin tablets)
7,943,582
8,513,202
Bracco Diagnostics Inc. v. Maia Pharms., Inc., 17-13151 (D.N.J.) Dec. 15, 2017 Hon. Peter G. Sheridan Kinevac® (sincalide for injection) 6,803,046
Arbor Pharms., LLC v. Taro Pharms. U.S.A., Inc., 17-9846 (S.D.N.Y.) Dec. 15, 2017 Hon. Sidney H. Stein Sklice® (ivermectin lotion)
8,791,153
8,927,595
Gilead Sciences, Inc. v. Mylan Pharms. Inc., 17-0217 (N.D.W.V.) Dec. 15, 2017 Hon. Irene M. Keeley Evotaz® (atazanavir / cobicistat tablets) 8,148,374
Onyx Therapeutics, Inc. v. Dr. Reddy's Labs., Inc., 17-1811 (D. Del.) Dec. 18, 2017 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection)
7,417,042
7,232,818
7,491,704
8,129,346
8,207,125
8,207,126
8,207,127
8,207,297
Eli Lilly and Co. v. Unichem Labs. Ltd., 17-13312 (D.N.J.) Dec. 19, 2017 Katharine S. Hayden Cialis® (tadalafil tablets) 6,943,166
Millennium Pharms., Inc. v. Qilu Pharm. Co., Ltd., 17-1830 (D. Del.) December 20, 2017 Hon. Gregory M. Sleet Velcade® (bortezomib for injection)
6,713,446
6,958,319
CyDex Pharms., Inc. v. Teva Pharms. USA, Inc., 17-1832 (D. Del.) Dec. 20, 2017 Hon. Leonard P. Stark Evomela® (melphalan HCl for Injection)
8,410,077
9,200,088
9,493,582
Onyx Therapeutics, Inc. v. MSN Pharms., Inc., 17-1833 (D. Del.) Dec. 20, 2017 Hon. Leonard P. Stark Kyprolis® (carfilzomib for injection) 7,737,112
Shire Development LLC v. Rhodes Pharms. L.P., 17-1840 (D. Del.) Dec. 21, 2017 Hon. Richard G. Andrews Adderall XR® (dextroamphetamine saccharate / amphetamine aspartate / dextroamphetamine sulfate / amphetamine sulfate extended-release capsules)
RE41,148
RE42,096
Impax Labs., Inc. v. Zydus Pharms. USA, Inc., 17-13476 (D.N.J.) Dec. 21, 2017 Hon. Stanley R. Chesler Rytary® (levodopa / carbidopa capsules) 9,089,608
Amgen Inc. v. Torrent Pharms. Ltd., 17-1844 (D. Del.) Dec. 22, 2017 Hon. Gregory M. Sleet Sensipar® (cinacalcet HCl tablets) 9,375,405
Initiative for Medicines, Access & Knowledge (I-MAK), Inc. v. Gilead Pharmasset LLC, IPR2018-00390 (PTAB) Dec. 26, 2017 N/A Sovaldi® (sofosbuvir tablets)XXHarvoni® (ledipasvir / sofosbuvir tablets)XXEpclusa® (sofosbuvir / velpatasvir tablets)XXVosevi® (sofosbuvir / velpatasvir / voxilaprevir tablets) 8,889,159
Glaxo Group Ltd. v. Aurobindo Pharma USA, Inc., 17-1862 (D. Del.) Dec. 27, 2017 Vacant Judgeship (2017) Lamictal XR® (lamotrigine extended-release tablets)
8,637,512
9,144,547
Osi Pharms., LLC v. Accord Healthcare Inc., USA, 17-1868 (D. Del.) Dec. 28, 2017 Hon. Gregory M. Sleet Tarceva® (erlotinib HCl tablets) 6,900,221
Mallinckrodt IP Unlimited Co. v. Aurobindo Pharma USA, Inc., 17-1877 (D. Del.) Dec. 29, 2017 Hon. Leonard P. Stark Ofirmev® (acetaminophen for injection)
6,992,218
9,399,012
9,610,265
Patheon Softgels Inc. v. Apotex Inc., 17-13819 (D.N.J.) Dec. 29, 2017 Hon. Michael A. Shipp naproxen sodium OTC Capsules
9,693,978
9,693,979
Back to Top